The credit rating agency expects long COVID-19 costs to reach $22 billion and account for 4% of annual medical expenditures in 2022.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}